AI assistant
Heranba Industries Limited — Earnings Release 2021
Jun 12, 2021
62011_rns_2021-06-12_124ad6c0-3280-4676-a1d2-c23c9b93c311.pdf
Earnings Release
Open in viewerOpens in your device viewer
PRESS RELEASE
==> picture [103 x 39] intentionally omitted <==
Heranba Industries Limited Reports FY 21 Results
Total Income of ₹12256.77 Mn; growth of 26.63% Profit After Tax at ₹1542.26 Mn; growth of 57.64% Board recommends dividend of ₹0.70 per share
Mumbai, Jun 11[th] , 2021: Heranba Industries Ltd. (BSE: 543266, NSE: HERANBA, ISIN: INE694N01015), one of India’s leading Synthetic Pyrethroids and its intermediates manufacturer in India, has announced its financial results for the fourth quarter and full-year ended March 31st, 2021.
Financial Highlights for Year Ended March 31st, 2021:
-
Total Income at ₹12,256.77 million in FY21 as compared to ₹9,679.06 million in FY20 – growth of 26.63% Y-o-Y.
-
EBITDA(incl. Other Income) at ₹2,283.69 million in FY21 as compared to ₹1,458.82 million in FY20 – growth of 56.54% Y-o-Y.
-
EBITDA(incl. Other income) Margins were at 18.74% in Q4FY21 as compared to 15.33% in Q4FY20 – growth of approx. 341bps.
-
Profit After Tax at ₹1,542.26 million in FY21 as compared to ₹976.57 million in FY20 – growth of 57.93% Y-o-Y.
-
Earnings Per Share (Diluted) was ₹39.41 in FY21 as compared to ₹25.00 in FY20 – growth of 57.64% Y- o-Y.
-
Cash and Cash equivalent stood at ₹847.80 million in FY21.
-
Company announced dividend of ₹0.70 per share i.e 7% of Face value ₹10 each in FY21.
Financial Highlights for Quarter Ended March 31st, 2021:
-
Total Income at ₹2,731.75 million in Q4FY21 as compared to ₹2,295.25 million in Q4FY20 – growth of 19.02% Y-o-Y.
-
EBITDA(incl. Other income) at ₹630.45 million in Q4FY21 as compared to ₹412.96 million in Q4FY20 – growth of 52.67% Y-o-Y.
-
EBITDA(incl. Other income) Margins were at 23.54% in Q4FY21 as compared to 19.33% in Q4FY20 – growth of approx. 421bps.
-
Profit After Tax at ₹431.99 million in Q4FY21 as compared to ₹262.64 million in Q4FY20 – growth of 64.48% Y-o-Y.
Mr. Raghuram K. Shetty, Managing Director of Heranba Industries Limited, commented, “We are pleased to report a robust performance in a rather challenging year. HIL grew its total income to 12,256 million, delivering a growth of 26.63%, this was supported by healthy performance in our overall product mix. The Company has also broken ground for its new CAPEX at Unit in Vapi, commercial production for which is expected to commence by Q3FY22. In addition, HIL has also acquired an industrial shed to enhance production capacity and upgrade its environmental pollution control facilities at Unit-2. This give us confidence in our future outlook for the Company, and we are confident on building on this growth trajectory as we move forward. ”
About Heranba Industries Limited:
Heranba is a leading agrochemical company in India. Heranba’s mission is to improve Crop Productivity and Public Health. It is committed to the wellness of world citizens. Heranba manufacturers Synthetic Pyrethroids and its intermediates in India. It has 4(four) manufacturing facilities across India with employee strength of more than 650. It has a wide network of businesses in India as well as across the globe. Heranba has expertise on all the key chemical reactions on commercial scale.
For more information on Heranba, please visit http://www.heranba.co.in
For further details please get in touch with:
Abdul Latif Mayura Bhusari/Nikhil Morye Heranba Industries Limited Christensen Advisory Tel No.: +91 22 2898 7912 Tel No.: +91 22 4215 0210 Email: [email protected] Email: [email protected] [email protected]
DISCLAIMER: Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. Heranba Industries Limited (Heranba) will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.